Preserved value of bone scintigraphy for the detection of skeletal metastases in prostate cancer patients with low prostate-specific antigen levels: effect of hormonal therapy and poor histologic differentiation

Clin Nucl Med. 2002 Jul;27(7):532-3. doi: 10.1097/00003072-200207000-00017.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Bone Neoplasms / blood
  • Bone Neoplasms / diagnostic imaging*
  • Bone Neoplasms / secondary*
  • Humans
  • Leg Bones / diagnostic imaging*
  • Male
  • Prostate-Specific Antigen / blood*
  • Prostatic Neoplasms / blood*
  • Prostatic Neoplasms / diagnostic imaging*
  • Prostatic Neoplasms / drug therapy
  • Prostatic Neoplasms / surgery
  • Radionuclide Imaging
  • Radiopharmaceuticals
  • Spine / diagnostic imaging*
  • Technetium Tc 99m Medronate
  • Whole-Body Counting

Substances

  • Radiopharmaceuticals
  • Prostate-Specific Antigen
  • Technetium Tc 99m Medronate